Table 1

Baseline characteristics data

Patient characteristicsMean ± SEM
Patients (n)60
Age (years)62.1 ± 1.4
Gender (male/female)32/28
BMI (kg/m2)28.6 ± 0.6
Lone AF25
Arterial hypertension (patients)32 (53%)
CAD (patients)12 (20%)
Diabetes mellitus (patients)5 (8%)
Smoker13 (21.7%)
LVH (patients)10 (16.7%)
Type of AF (paroxysmal/persistent)44/16 (73.3/26.7%)
Duration of AF (years)5.4 ± 0.89
Ineffective antiarrhythmic drugs (n = 0/1/2/3)4/34/21/1 (6.6/56.7/35/1.7%)
EF < 55%4 (6.7%)
Mean LAD (mm)45.5 ± 1.2
Mean LA area (cm2)24.7 ± 1.8
Mean LA volume (mL) in MDCT/CMRI89.3 ± 3.9
Patient characteristicsMean ± SEM
Patients (n)60
Age (years)62.1 ± 1.4
Gender (male/female)32/28
BMI (kg/m2)28.6 ± 0.6
Lone AF25
Arterial hypertension (patients)32 (53%)
CAD (patients)12 (20%)
Diabetes mellitus (patients)5 (8%)
Smoker13 (21.7%)
LVH (patients)10 (16.7%)
Type of AF (paroxysmal/persistent)44/16 (73.3/26.7%)
Duration of AF (years)5.4 ± 0.89
Ineffective antiarrhythmic drugs (n = 0/1/2/3)4/34/21/1 (6.6/56.7/35/1.7%)
EF < 55%4 (6.7%)
Mean LAD (mm)45.5 ± 1.2
Mean LA area (cm2)24.7 ± 1.8
Mean LA volume (mL) in MDCT/CMRI89.3 ± 3.9

Echocardiographic data presented in italics.

Table 1

Baseline characteristics data

Patient characteristicsMean ± SEM
Patients (n)60
Age (years)62.1 ± 1.4
Gender (male/female)32/28
BMI (kg/m2)28.6 ± 0.6
Lone AF25
Arterial hypertension (patients)32 (53%)
CAD (patients)12 (20%)
Diabetes mellitus (patients)5 (8%)
Smoker13 (21.7%)
LVH (patients)10 (16.7%)
Type of AF (paroxysmal/persistent)44/16 (73.3/26.7%)
Duration of AF (years)5.4 ± 0.89
Ineffective antiarrhythmic drugs (n = 0/1/2/3)4/34/21/1 (6.6/56.7/35/1.7%)
EF < 55%4 (6.7%)
Mean LAD (mm)45.5 ± 1.2
Mean LA area (cm2)24.7 ± 1.8
Mean LA volume (mL) in MDCT/CMRI89.3 ± 3.9
Patient characteristicsMean ± SEM
Patients (n)60
Age (years)62.1 ± 1.4
Gender (male/female)32/28
BMI (kg/m2)28.6 ± 0.6
Lone AF25
Arterial hypertension (patients)32 (53%)
CAD (patients)12 (20%)
Diabetes mellitus (patients)5 (8%)
Smoker13 (21.7%)
LVH (patients)10 (16.7%)
Type of AF (paroxysmal/persistent)44/16 (73.3/26.7%)
Duration of AF (years)5.4 ± 0.89
Ineffective antiarrhythmic drugs (n = 0/1/2/3)4/34/21/1 (6.6/56.7/35/1.7%)
EF < 55%4 (6.7%)
Mean LAD (mm)45.5 ± 1.2
Mean LA area (cm2)24.7 ± 1.8
Mean LA volume (mL) in MDCT/CMRI89.3 ± 3.9

Echocardiographic data presented in italics.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close